Wn Pharmaceuticals · 99-39 · CANADA
For Wn Pharmaceuticals · 99-39 · CANADA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is CANADA; product is OMEGA-3 & CoQ10 WITH PLANT STEROLS | Glucosamine and Chondroitin Sulfate | OMEGA-3 & CoQ10 WITH PLANT STEROLS | Glucosamine and Chondroitin Sulfate | Glucosamine and Chondroitin Sulfate; product code is 54 Y - - 08 Coenzyme Q10 (Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, N.E.C.) | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 55 P - - 01 Glucosamine (Pharmaceutic Necessity) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 10/02/2015; address is 2000 Brigantine Dr , Coquitlam, British Columbia CANADA, verified against its source on 2026-09-16.
- Firm
- Wn Pharmaceuticals verified
- Import alert
- 99-39
- Import alert name
- Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- Country
- CANADA verified
- Address
- 2000 Brigantine Dr , Coquitlam, British Columbia CANADA verified
- Date published
- 10/02/2015 verified
- Product code
- 54 Y - - 08 Coenzyme Q10 (Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, N.E.C.) | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 55 P - - 01 Glucosamine (Pharmaceutic Necessity) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- OMEGA-3 & CoQ10 WITH PLANT STEROLS | Glucosamine and Chondroitin Sulfate | OMEGA-3 & CoQ10 WITH PLANT STEROLS | Glucosamine and Chondroitin Sulfate | Glucosamine and Chondroitin Sulfate each item verified
- FDA notes
- The article is subject to refusal of admission pursuant to section 801(a)(3) of the Act in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. ?343(q)(5)(F)] because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. | The product appears to be misbranded within the meaning of; (1) section 403 (q)(5)(F) of the Act because it fails to present nutrition information in a Supplement Facts panel as required by 21 CFR 101.36 (e). Furthermore; it appears that glucosamine sulfate is a dietary ingredient in the product. However; the nutrition information does not clearly identify the source of the dietary ingredient as required by 21 CFR 101.36(d)(1) and 101.4(a)(1) and (g) and (2) section 403(s)(2)(B) because it fails to include a statement of identity as a dietary supplement; as required by 21 CFR 101.3(g). | The article is subject to refusal of admission pursuant to section 801(a)(3) of the Act in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. ?343(q)(5)(F)] because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. | The product appears to be misbranded within the meaning of; (1) section 403(q)(5)(F) of the Act because it fails to present nutrition information in a Supplement Facts panel as required by 21 CFR 101.36 (e). Furthermore; it appears that glucosamine sulfate is a dietary ingredient in the product. However; the nutrition information does not clearly identify the source of the dietary ingredient as required by 21 CFR 101.36(d)(1) and 101.4(a)(1) and (g) and (2) section 403(s)(2)(B) because it fails to include a statement of identity as a dietary supplement; as required by 21 CFR 101.3(g). | The product appears to be misbranded within the meaning of; (1) section 403(q)(5)(F) of the Act because it fails to present nutrition information in a Supplement Facts panel as required by 21 CFR 101.36 (e). Furthermore; it appears that glucosamine sulfate is a dietary ingredient in the product. However; the nutrition information does not clearly identify the source of the dietary ingredient as required by 21 CFR 101.36(d)(1) and 101.4(a)(1) and (g) and (2) section 403(s)(2)(B) because it fails to include a statement of identity as a dietary supplement; as required by 21 CFR 101.3(g). each item verified
What the source says
Wn Pharmaceuticals Date Published : 10/02/2015 2000 Brigantine Dr , Coquitlam, British Columbia CANADA 54 Y - - 08 Coenzyme Q10 (Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, N.E.C.) Date Published: 10/02/2015 Desc: OMEGA-3 & CoQ10 WITH PLANT STEROLS Notes: The article is subject to refusal of admission pursuant to section 801(a)(3) of the Act in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. ?343(q)(5)(F)] because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 06/21/2016 Desc: Glucosamine and Chondroitin Sulfate Notes: The product appears to be misbranded within the meaning of; (1) section 403 (q)(5)(F) of the Act because it fails to present nutrition information in a Supplement Facts panel as required by 21 CFR 101.36 (e). Furthermore; it appears that glucosamine sulfate is a dietary ingredient in the product. However; the nutrition information does not clearly identify the source of the dietary ingredient as required by 21 CFR 101.36(d)(1) and 101.4(a)(1) and (g) and (2) section 403(s)(2)(B) because it fails to include a statement of identity as a dietary supplement; as required by 21 CFR 101.3(g). 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 10/02/2015 Desc: OMEGA-3 & CoQ10 WITH PLANT STEROLS Notes: The article is subject to refusal of admission pursuant to section 801(a)(3) of the Act in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. ?343(q)(5)(F)] because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. 55 P - - 01 Glucosamine (Pharmaceutic Necessity) Date Published: 06/21/2016 Desc: Glucosamine and Chondroitin Sulfate Notes: The product appears to be misbranded within the meaning of; (1) section 403(q)(5)(F) of the Act because it fails to present nutrition information in a Supplement Facts panel as required by 21 CFR 101.36 (e). Furthermore; it appears that glucosamine sulfate is a dietary ingredient in the product. However; the nutrition information does not clearly identify the source of the dietary ingredient as required by 21 CFR 101.36(d)(1) and 101.4(a)(1) and (g) and (2) section 403(s)(2)(B) because it fails to include a statement of identity as a dietary supplement; as required by 21 CFR 101.3(g). 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/21/2016 Desc: Glucosamine and Chondroitin Sulfate Notes: The product appears to be misbranded within the meaning of; (1) section 403(q)(5)(F) of the Act because it fails to present nutrition information in a Supplement Facts panel as required by 21 CFR 101.36 (e). Furthermore; it appears that glucosamine sulfate is a dietary ingredient in the product. However; the nutrition information does not clearly identify the source of the dietary ingredient as required by 21 CFR 101.36(d)(1) and 101.4(a)(1) and (g) and (2) section 403(s)(2)(B) because it fails to include a statement of identity as a dietary supplement; as required by 21 CFR 101.3(g).
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_1144.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.